EDTA chelation therapy does not selectively increase chromium losses

Biological Trace Element Research

Volumn 70, Issue 3, 1999, Pages 265-272

  Anderson, Richard A ^a,b   Bryden, Noella A ^a,b   Waters, Robert ^a,b  

^a BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

^b Waters Preventive Medicine Center   (United States)

Author keywords

Chelation therapy; Chromium; Diabetes; EDTA; Trace elements

Indexed keywords

CHROMIUM; EDETIC ACID;

ADULT; AGED; ARTICLE; CHELATION THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HUMAN; MALE; METAL METABOLISM; TREATMENT OUTCOME; URINALYSIS; URINARY EXCRETION;

EID: 0032692895     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02783835     Document Type: Article

References (17)

1. E. M. Cranton and J. P. Frackelton, Free radical pathology in age-associated diseases: Treatment with EDTA chelation, nutrition, and antioxidants, J. Adv. Med. 2, 17-54 (1989).
2. R. A. Anderson, Recent advances in the clinical and biochemical manifestation of chromium deficiency in human and animal nutrition, J. Trace Element Exp. Med. 11, 241-250 (1998).
3. L. T. Chappell and M. Janson, EDTA chelation therapy in the treatment of vascular disease, J. Cardiovasc. Nutr. 10, 78-86 (1996).
4. E. M. Cranton, Z. X. Liu, and I. M. Smith, Urinary trace and toxic elements and minerals in untimed urine specimens relative to urine creatinine, Part 1: Concentrations of elements in fasting urine, J. Adv. Med. 2, 331-348 (1989).
5. R. A. Anderson, Stress effects on chromium nutrition of humans and farm animals, in Proc. Alltech's Tenth Symposium Biotechnology in the Feed Industry, Nottingham University Press, Loughbrough, England, pp. 267-274 (1994).
6. R. A. Anderson and A. S. Kozlovsky, Chromium intake, absorption and excretion of subjects consuming self-selected diets, Am. J. Clin. Nutr. 41, 1177-1183 (1985).
7. R. A. Anderson, N. A. Bryden, and M. M. Polansky, Dietary chromium intake-freely chosen diets, institutional diets and individual foods, Biol. Trace Element Res. 32, 117-121 (1992).
8. D. W. Cockcroft and M. H. Gault, Prediction of creatinine clearance from serum creatinine, Nephron 16, 31-41 (1976).
9. R. A. Anderson, M. M. Polansky, N. A. Bryden, K. Y. Patterson, C. Veillon, and W. Glinsmann, Effects of chromium supplementation on urinary Cr excretion of human subjects and correlation of Cr excretion with selected clinical parameters, J. Nutr. 113, 276-281 (1983).
10. C. Veillon, W. R. Wolf, and B. E. Guthrie, Determination of chromium in biological materials by stable isotope dilution, Anal. Chem. 51, 1022-1024 (1979).
11. A. Popovici, C. F. Geschichter, A. Reinovsky, and M. Rubin, Experimental control of serum calcium levels in vivo, Proc. Soc. Exp. Biol. Med. 74, 415-422 (1950).
12. N. E. Clarke, C. N. Clarke, and R. E. Moscher, Treatment of angina pectoris with disodium ethylene diamine tetraacetic acid, Am. J. Med. Sci. 4, 654-666 (1956).
13. S. K. Tandon and J. S. Gaur, Chelation in metal intoxication. IV. Removal of chromium from organs of experimentally poisoned animals, Clin. Toxicol. 11, 257-264 (1977).
14. W. Banner, Jr., M. Koch, D. M. Capin, S. B. Hopf, S. Chang, and T. G. Tong, Experimental chelation therapy in chromium, lead and boron intoxication with N-acetyl-cysteine and other compounds, Toxicol. Appl. Pharmacol. 83, 142-147 (1986).
15. F. Sata, S. Araki, K. Murata, and H. Aono, Behavior of heavy metals in human urine and blood following calcium disodium ethylenediamine tetraacetate injection: Observations in metal workers, J. Toxicol. Environ. Health 54, 167-178 (1988).
16. R. A. Anderson, N. A. Bryden, M. M. Polansky, and J. W. Thorp, Effect of carbohydrate loading and underwater exercise on circulating cortisol, insulin and urinary losses of chromium and zinc, Eur. J. Appl. Physiol. 63, 146-150 (1991).
17. L. S. Goodman and A. Gilman, The Pharmacological Basis of Therapeutics, 3rd Ed., MacMillian Co., New York, p. 950 (1985).